Display options
Cite
Gisselsson D, Lundberg G, Ora I, et al. Distinct evolutionary mechanisms for genomic imbalances in high-risk and low-risk neuroblastomas. J Carcinog. 2007;6:15doi: 10.1186/1477-3163-6-15.
Gisselsson, D., Lundberg, G., Ora, I., & Höglund, M. (2007). Distinct evolutionary mechanisms for genomic imbalances in high-risk and low-risk neuroblastomas. Journal of carcinogenesis, 615. https://doi.org/10.1186/1477-3163-6-15
Gisselsson, David, et al. "Distinct evolutionary mechanisms for genomic imbalances in high-risk and low-risk neuroblastomas." Journal of carcinogenesis vol. 6 (2007): 15. doi: https://doi.org/10.1186/1477-3163-6-15
Gisselsson D, Lundberg G, Ora I, Höglund M. Distinct evolutionary mechanisms for genomic imbalances in high-risk and low-risk neuroblastomas. J Carcinog. 2007 Sep 26;6:15. doi: 10.1186/1477-3163-6-15. PMID: 17897457; PMCID: PMC2042979.
Copy Download .nbib Format: NLM
Share it on

J Carcinog. 2007 Sep 26;6:15. doi: 10.1186/1477-3163-6-15.

Distinct evolutionary mechanisms for genomic imbalances in high-risk and low-risk neuroblastomas.

Journal of carcinogenesis

David Gisselsson, Gisela Lundberg, Ingrid Ora, Mattias Höglund

Affiliations

  1. Department of Clinical Genetics, Lund University Hospital, SE 221 85 Lund, Sweden. [email protected].

PMID: 17897457 PMCID: PMC2042979 DOI: 10.1186/1477-3163-6-15

Abstract

BACKGROUND: Neuroblastoma (NB) is the most common extracranial solid tumour of childhood. Several genomic imbalances correlate to prognosis in NB, with structural rearrangements, including gene amplification, in a near-diploid setting typically signifying high-risk tumours and numerical changes in a near-triploid setting signifying low-risk tumours. Little is known about the temporal sequence in which these imbalances occur during the carcinogenic process.

METHODS: We have reconstructed the appearance of cytogenetic imbalances in 270 NBs by first grouping tumours and imbalances through principal component analysis and then using the number of imbalances in each tumour as an indicator of evolutionary progression.

RESULTS: Tumours clustered in four sub-groups, dominated respectively by (1) gene amplification in double minute chromosomes and few other aberrations, (2) gene amplification and loss of 1p sequences, (3) loss of 1p and other structural aberrations including gain of 17q, and (4) whole-chromosome gains and losses. Temporal analysis showed that the structural changes in groups 1-3 were acquired in a step-wise fashion, with loss of 1p sequences and the emergence of double minute chromosomes as the earliest cytogenetic events. In contrast, the gains and losses of whole chromosomes in group 4 occurred through multiple simultaneous events leading to a near-triploid chromosome number.

CONCLUSION: The finding of different temporal patterns for the acquisition of genomic imbalances in high-risk and low-risk NBs lends strong support to the hypothesis that these tumours are biologically diverse entities, evolving through distinct genetic mechanisms.

References

  1. N Engl J Med. 1999 Jun 24;340(25):1954-61 - PubMed
  2. J Clin Oncol. 1993 Aug;11(8):1466-77 - PubMed
  3. Genes Chromosomes Cancer. 2000 Oct;29(2):89-95 - PubMed
  4. Genes Chromosomes Cancer. 2001 Jun;31(2):156-71 - PubMed
  5. Ann Genet. 2001 Jul-Sep;44(3):161-6 - PubMed
  6. Cancer Res. 2002 May 1;62(9):2675-80 - PubMed
  7. Genes Chromosomes Cancer. 2002 Jul;34(3):313-24 - PubMed
  8. Cancer Genet Cytogenet. 2002 Jun;135(2):103-9 - PubMed
  9. Cancer Res. 2002 Oct 15;62(20):5939-46 - PubMed
  10. Nat Rev Cancer. 2003 Mar;3(3):203-16 - PubMed
  11. Cancer Res. 2003 Jun 15;63(12):3378-85 - PubMed
  12. Cancer Genet Cytogenet. 2004 Apr 1;150(1):9-15 - PubMed
  13. Pediatr Blood Cancer. 2005 Feb;44(2):147-57 - PubMed
  14. Genes Chromosomes Cancer. 2005 Apr;42(4):327-41 - PubMed
  15. J Clin Oncol. 2005 Apr 1;23(10):2280-99 - PubMed
  16. Int J Cancer. 2005 Sep 1;116(3):401-6 - PubMed
  17. Genes Chromosomes Cancer. 2005 Oct;44(2):113-22 - PubMed
  18. N Engl J Med. 2005 Nov 24;353(21):2243-53 - PubMed
  19. Cancer Genet Cytogenet. 2006 May;167(1):51-6 - PubMed
  20. Genes Chromosomes Cancer. 2006 Dec;45(12):1130-42 - PubMed
  21. J Pediatr Surg. 2006 Dec;41(12):2032-6 - PubMed
  22. PLoS One. 2007;2(2):e255 - PubMed
  23. Cancer. 1989 Jan 1;63(1):126-32 - PubMed
  24. J Pediatr. 1988 Apr;112(4):567-71 - PubMed
  25. Cancer Res. 1987 Jan 1;47(1):311-8 - PubMed
  26. N Engl J Med. 1985 Oct 31;313(18):1111-6 - PubMed
  27. Eur J Cancer. 2000 May;36(7):901-8 - PubMed

Publication Types